Published in Cancer Weekly, June 21st, 2011
"The programme, started in 1972, has become an international authoritative reference and represents an early 'evidence-based' development bringing together a comprehensive evaluation of both...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.